Researcher Profile Statistics: R Abirami
Geo Map
Region
#
AS - Asia, other
130
NA - North America
26
EU - Europe
4
Unknown
5
Total
165
Country
#
SG - Singapore
109
US - United States of America
26
HK - Hong Kong
13
CN - China
6
DE - Germany
3
PH - Philippines
2
IE - Ireland
1
Unknown
5
Total
165
City
#
Singapore
103
Hong Kong
12
Ashburn
8
Shanghai
3
Boardman
2
Pangil
2
Beijing
1
Cincinnati
1
Dublin
1
Prineville
1
other
31
Total
165
Most viewed items
#
ID: 242833 - Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants
165
Total: {0}
165
Most type viewed
#
ID: other -
0
ID: journal -
165
ID: conference -
0
ID: patent -
0
ID: allItems -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
165
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2022
0 0
0 0 0 0
0 0 0 0
13 6
19
2023
1 5
7 5 6 9
5 6 8 6
17 7
82
2024
7 5
7 8 8 8
11 8 2 0
0 0
64
Ever
165
Geo Map
Region | # |
---|---|
AS - Asia, other | 130 |
NA - North America | 26 |
EU - Europe | 4 |
Unknown | 5 |
Total | 165 |
Country | # |
---|---|
SG - Singapore | 109 |
US - United States of America | 26 |
HK - Hong Kong | 13 |
CN - China | 6 |
DE - Germany | 3 |
PH - Philippines | 2 |
IE - Ireland | 1 |
Unknown | 5 |
Total | 165 |
City | # |
---|---|
Singapore | 103 |
Hong Kong | 12 |
Ashburn | 8 |
Shanghai | 3 |
Boardman | 2 |
Pangil | 2 |
Beijing | 1 |
Cincinnati | 1 |
Dublin | 1 |
Prineville | 1 |
other | 31 |
Total | 165 |
Most viewed items | # |
---|---|
ID: 242833 - Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants | 165 |
Total: {0} | 165 |
Most type viewed | # |
---|---|
ID: other - | 0 |
ID: journal - | 165 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: allItems - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 165 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 6 | 19 |
2023 | 1 | 5 | 7 | 5 | 6 | 9 | 5 | 6 | 8 | 6 | 17 | 7 | 82 |
2024 | 7 | 5 | 7 | 8 | 8 | 8 | 11 | 8 | 2 | 0 | 0 | 0 | 64 |
Ever | 165 |